603963 Dali Pharmaceutical operation suggestions
[Baoxin Technology: Lianyungang Baoxin Optoelectronics is currently under construction production capacity of 500MW/year, and is expected to be put into production by the end of January next year] Baoxin Technology stated on the interactive platform that Lianyungang Baoxin Optoelectronics Technology Co., Ltd. is a holding subsidiary specializing in the production and sales of photovoltaic components. The current under construction capacity is 500MW/year, and is expected to be put into production by the end of January next year.
[ Meilian New Materials : The fourth quarter is the traditional peak season for pyrocyanum chlorine , and the current production and sales are both prosperous] Meilian New Materials said on the interactive platform that the sales of pyrocyanum chlorine have obvious seasonal characteristics. The fourth quarter is the traditional peak season for pyrocyanum chlorine, and the current production and sales are both prosperous.
[Yuxin Electronics has established an intelligent technology subsidiary in Zhejiang, and its business scope includes battery manufacturing] Qichacha APP shows that on October 18, Zhejiang Pingrui Intelligent Technology Co., Ltd. was established with a registered capital of RMB 50 million, and its business scope includes: manufacturing of automobile parts and accessories; battery manufacturing; retail of automobile parts; sales of plug-in hybrid special engines, etc. Qichacha equity penetration shows that the company is 100% controlled by Yuxin Electronics.
[Taihe New Materials : The company has no plans to intervene in the F-12 fiber market yet]Taihe New Materials replied on the interactive platform that the company has investigated related products for the latest F-12 fibers, but due to its small market space, the company has no plans to intervene. Recently, my country's key technologies for cutting-edge aerospace materials have achieved breakthroughs, and high-performance fibers, namely F-12 aramid fiber, have been domestically produced. The news has attracted market attention. Some investors asked about the difference between Taihe New Materials' high-end aramid and this F-12. In response, the company stated that F-12 belongs to Aramid Ⅲ and Para-aramid belongs to Aramid Ⅱ. Compared with the two, Aramid Ⅲ has better performance but is too high in cost, and the cost performance and market space are far from Aramid Ⅱ.
Last operation strategy: 603963 Dali Pharmaceutical callback 13.99 nearby intervention.
(This article was released at 2 am on October 19, 2022. The operation suggestions are for reference only and are valid on the same day only)